Likewise, an impaired potential for invasion, as assessed by Matrigel transwell assays (characteristic of A375 malignant melanoma cells with GLO1 deletion), was fully reversed by CMV-driven GLO1 re-expression (Figure 6I). Here, GLO1 is linked to melanoma.